BioKDE: Biomedical Knowledge Discovery Engine
Sorted by:  
Results by Year
Article Type
Publication date


Custom range



  398,997 results (0.364 seconds)
Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness.
Fei Peng, Magdiel Inggrid Setyawati, +5 authors, David Tai Leong.
Nat Nanotechnol. 2019 Jan 28; 14(3):279-286. PMID: 30692675
Highly Cited.
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).
M J Duffy, N Harbeck, +4 authors, F Cardoso.
Eur J Cancer. 2017 Feb 28; 75:284-298. PMID: 28259011
Highly Cited. Review.
Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA.
Erin L Hayes,  Joan S Lewis-Wambi.
Breast Cancer Res. 2015 Mar 17; 17:40. PMID: 25849966     Free PMC article
Highly Cited. Review.
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review.
Sasha E Stanton,  Sylvia Adams,  Mary L Disis.
JAMA Oncol. 2016 Jun 30; 2(10):1354-1360. PMID: 27355489
Highly Cited. Systematic Review. Review.
Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype.
Gregg L Semenza.
EMBO J. 2016 Dec 22; 36(3):252-259. PMID: 28007895     Free PMC article
Highly Cited. Review.
Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Heidi D Nelson, Miranda Pappas, +3 authors, Linda Humphrey.
Ann Intern Med. 2016 Jan 12; 164(4):256-67. PMID: 26756737
Highly Cited. Systematic Review. Review.
Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development.
Ricardo Costa, Ami N Shah, +7 authors, Francis J Giles.
Cancer Treat Rev. 2017 Jan 05; 53:111-119. PMID: 28104566
Highly Cited. Review.
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.
Jack Cuzick, Ivana Sestak, +14 authors, SERM Chemoprevention of Breast Cancer Overview Group.
Lancet. 2013 Apr 30; 381(9880):1827-34. PMID: 23639488     Free PMC article
Highly Cited. Review.
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
Kala Visvanathan, Patricia Hurley, +16 authors, Scott M Lippman.
J Clin Oncol. 2013 Jul 08; 31(23):2942-62. PMID: 23835710
Highly Cited. Systematic Review. Review.
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial.
Sherene Loi, Anita Giobbie-Hurder, +18 authors, International Breast Cancer Study Group and the Breast International Group.
Lancet Oncol. 2019 Feb 11; 20(3):371-382. PMID: 30765258
Highly Cited.
Streamlining breast cancer and colorectal cancer biosimilar regulations to improve treatment access in Latin America: an expert panel perspective.
Enrique Teran, Henry Gomez, +7 authors, Manuel Antonio Espinoza.
Lancet Oncol. 2022 Jul 01; 23(7):e348-e358. PMID: 35772466
Review.
Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.
Eleni van Schooneveld, Hans Wildiers, +3 authors, Steven J Van Laere.
Breast Cancer Res. 2015 Feb 18; 17:21. PMID: 25849621     Free PMC article
Highly Cited. Review.
Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.
John A Barry,  Mallika M Azizia,  Paul J Hardiman.
Hum Reprod Update. 2014 Mar 30; 20(5):748-58. PMID: 24688118     Free PMC article
Highly Cited. Systematic Review. Review.
The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer.
Britta Weigelt,  Cyrus M Ghajar,  Mina J Bissell.
Adv Drug Deliv Rev. 2014 Jan 09; 69-70:42-51. PMID: 24412474     Free PMC article
Highly Cited. Review.
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Heidi D Nelson, Rochelle Fu, +3 authors, Linda Humphrey.
Ann Intern Med. 2016 Jan 12; 164(4):244-55. PMID: 26756588
Highly Cited. Systematic Review. Review.
Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies.
D S M Chan, A R Vieira, +7 authors, T Norat.
Ann Oncol. 2014 Apr 27; 25(10):1901-1914. PMID: 24769692     Free PMC article
Highly Cited. Systematic Review. Review.
Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis.
D Schmid,  M F Leitzmann.
Ann Oncol. 2014 Mar 18; 25(7):1293-1311. PMID: 24644304
Highly Cited. Systematic Review. Review.
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Lancet Oncol. 2017 Dec 11; 19(1):27-39. PMID: 29242041     Free PMC article
Highly Cited. Review.
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.
Leonie Voorwerk, Maarten Slagter, +31 authors, Marleen Kok.
Nat Med. 2019 May 13; 25(6):920-928. PMID: 31086347
Highly Cited.
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
Collaborative Group on Hormonal Factors in Breast Cancer.
Lancet. 2019 Aug 29; 394(10204):1159-1168. PMID: 31474332     Free PMC article
Highly Cited.
Previous 1 2 3 4 5 6 7 8 9 10 Next